Emily Ethridge covers health care policy as a staff writer for CQ Roll Call. Prior to that, she covered several committees, the Senate floor, and the House floor as part of CQ's legislative action team. She also wrote for a newsletter covering the prescription drug and medical device industries.
A native of Charlotte, North Carolina, Emily has lived in the District of Columbia since graduating from the Johns Hopkins University with a degree in Writing Seminars. She currently lives in the Logan Circle neighborhood and enjoys trying to keep up with her fellow runners at CQ Roll Call.
Appropriators are expected to include significant extra funding in an omnibus spending package to help agencies continue responding to the Ebola outbreak, but the final number will be less than President Barack Obama requested.
Lawmakers are using the Ebola outbreak to call for a broader investment in biomedical research and public health funding to avoid scrambling to respond to a specific disease.
House GOP leaders are likely to float a proposal in their conference next week to fund most government agencies through September 2015, while providing a shorter-term stopgap component for immigration-related programs and initiatives.
A movement is growing among rank-and-file House Republicans to explicitly ban funding for White House executive actions on immigration.
With the White House weighing more air strikes against jihadists in northern Iraq and possibly Syria, Rep. John B. Larson said Congress needs to cancel its August recess and get back to work in Washington.
President Barack Obama called for calm in Ferguson, Mo., on Thursday, and said the FBI and Department of Justice are both launching independent investigations into the police shooting of an unarmed teenager.
Updated 12:53 p.m. | Lawmakers are beginning to speak out in reaction to the protests and police response in Ferguson, Mo., following the killing of an unarmed African-American teenager by police on Aug 9.
The implosion of Eric Cantor’s majority leader operation left a sudden gap atop the House GOP that a new crop of Republicans are eyeing hungrily. By scheduling a snap election, the current leadership appeared to cement current Republican Whip Kevin McCarthy of California as the front-runner to replace Cantor in leadership elections scheduled for June 19. But jockeying is expected to continue in the days leading up to balloting, and a McCarthy ascension would trigger a reshuffling of the leadership posts below him.
On America’s southern border, officials have watched for the past few years as a trickle of children crossing the Rio Grande illegally without their parents has turned into a veritable flood. So many kids, in fact, that the issue has triggered a crisis, as Secretary of Homeland Security Jeh Johnson had to issue an emergency alert this month establishing a shelter at Lackland Air Force Base in Texas to house the thousands of youths entering each week.
The last time Rep. Dana Rohrabacher offered an amendment on the House floor to protect states rights when it came to legalization of medical marijuana, it was defeated 163–262.
One of the Food and Drug Administration’s newest tools in trying to protect consumers from counterfeit or contaminated drugs is a system to enhance tracking of products throughout the distribution chain.
The Food and Drug Administration is tasked with overseeing the safety and quality of most of the food, medical devices, drugs, biological products, vaccines and cosmetics in the United States. But every year, more and more of those products come into the country from other nations.
With all the enthusiasm and energy to get rid of the flawed system that Medicare uses to pay physicians, why isn’t it gone yet?
Provider groups have often raised the specter of physicians shutting their door to Medicare patients as a possible consequence of the perpetually looming Medicare physician payment cuts. But administration officials and the independent Medicare Payment Advisory Committee say the problem is not as dire as some suggest.
In 2012, lawmakers hailed legislation that outlawed the sale of 26 designer drugs — substances meant to mimic the properties of illegal drugs such as marijuana or cocaine. The synthetics have been linked to incidences of violence, overdoses and suicides.
The prosecution of manufacturers and distributors of synthetic drugs presents different challenges from going after typical drug dealers, law enforcement officials say.
With the government days away from shutting down, and Republicans still searching for votes on a measure to raise the debt ceiling, House Majority Leader Eric Cantor took some time Thursday to focus on what’s really important: the children.
Senators hope that they will soon get a chance to quickly pass legislation that would give the Food and Drug Administration more authority over compounding pharmacies. For months, lawmakers in both chambers have been working on the best way to respond to last year’s fatal fungal meningitis outbreak linked to a contaminated compounded drug.
Although lawmakers are working to increase oversight of some compounding pharmacies, they agree that the practice of traditional compounding serves an important purpose and should be protected.
Beachgoers reaching for the sunscreen this summer may notice some new labels on the bottles, including warnings that the product may not protect against skin cancer.
Salt may be at the heart of a dietary disagreement, but it’s also the main ingredient in a billion-dollar American industry.
A month after House Republican leaders were forced to pull an unpopular Obamacare revision from the House floor, bill sponsor Rep. Joe Pitts, R-Pa., said he expects to see a modified version under consideration again in “a couple of weeks.”
The Food and Drug Administration is able to do its work in part because of a symbiotic relationship with the industries it regulates. But recently that relationship has been knocked off balance.
Conservative groups and some lawmakers are pushing Republicans to focus on legislation that would ruin the health care law’s implementation — a strategy that complicates efforts to pass any other kind of health care bill.
Lawmakers and congressional staff members are concerned about whether the federal government will continue to pay part of their premiums as they move to buying insurance through the exchanges next year.